Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer.
Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment opt...
| Publicado en: | Current Oncology Vol. 29; no. 7; pp. 4748 - 4768 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Jul2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |